Intervention

Umbilical Cord Mesenchymal Stem Cells

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting2

Common conditions7

Lead sponsors shown4

Clinical trials

4 shown

Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical TrialNCT07396155 · 2026-07-01

Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD PatientsNCT07441226 · 2025-08-08

Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes MellitusNCT04441658 · 2020-04-10

Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular ComplicationsNCT02834858 · 2016-01-01

Common conditions

Chronic Obstructive Pulmonary Disease (COPD)1 Diabetic Foot1 Diabetic Nephropathy Type 21 Ischemia1 Mesenchymal Stem Cells1 Peripheral Vascular Disease1 Type 2 Diabetes1

Leading sponsors

Jie Shen1 PT. Prodia Stem Cell Indonesia1 RSUP Persahabatan1 Shanghai East Hospital1

Trial status mix

RECRUITING2

UNKNOWN2

Phase mix

PHASE13

PHASE23

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.